News Daily News European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba Michael O'Riordan September 15, 2023
News Daily News FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl Michael O'Riordan November 14, 2019
News Daily News Biotin Supplements Can Interfere With Cardiac Troponin Tests: FDA Michael O'Riordan November 28, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2017 Shelley Wood September 30, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for May 2017 Shelley Wood June 01, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for August 2016 Caitlin E. Cox September 01, 2016
News Daily News USPSTF: Not Enough Evidence to Recommend Routine Lipid Screening in Children and Adolescents Michael O'Riordan August 09, 2016
News Daily News FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin Michael O'Riordan June 30, 2016
News Daily News Un Panel Asesor de la FDA Recomienda por un Estrecho Margen una Indicación de Mortalidad por EAC para el Antidiabético Empagliflozina Michael O'Riordan June 30, 2016